Latest

With the backing of the president, Mexico's Senate has approved medical marijuana; Kentucky's attorney general identifies the opioid epidemic as the state's biggest problem, Nevada drug dogs trained to sniff out marijuana face an uncertain future after legalization, and more.

There's a lot of international news today, plus Colorado pot sales pass the $1 billion mark this year, Massachusetts politicians get out of the way of legalization, and more.

A bipartisan effort to goose federal marijuana reforms is underway, a bill that would establish a hemispheric drug policy review heads for the president's desk, the Israeli anti-drug body makes a surprise move, and more.

Trump's anti-marijuana attorney general pick gets a surprise visit from DC activists, the CDC announces that opioid OD deaths went up again last year, British Columbia expands its safe injection site program, and more.

The bad news is that drug war deaths just keep coming. The good news is that they seem to be coming just a bit less frequently.

Another Trump nominee raising eyebrows and concerns among drug reformers, Congress passes a health care omnibus bill that includes $1 billion for opioid treatment, Montana dispensaries are cleared to reopen, and more.

Advocates file a petition to rein in DEA misinformation about medical marijuana, Arkansas regulators are moving to implement the new law there, Minnesota adds PTSD, and more.

A bunch of Des Moines drug cases are now in doubt after a pair of cops are accused of planting drugs, a former New York cop gets sent away for selling "date rape" drugs, and more.

An organic foods group says allowing kratom would be "dangerous," the Drug Policy Alliance comes out with a plan for heroin and prescription opioids, Iowa shuts down its asset forfeiture unit, and more.

Medical marijuana advocates want the DEA to quit fibbing about weed, Massachusetts pols say they may delay implementation of legal pot commerce, a medical marijuana bill gets filed in Texas, and more.

Foes challenging the narrow legalization victory in Maine got their recount going today, patients take to the courts in Arizona and to the streets in Michigan, Seattle health care professionals do a die-in for safe injection sites, Ireland takes another step toward medical marijuana, and more.

Donald Trump doesn't appear overly concerned with the mass killings and human rights violations taking place in the Philippines' drug war.

Election Day saw the number of states with marijuana legalization double, and the number of people living in legalization states quadruple. But there won't be more ballot initiatives until 2018 at the earliest. Reformers are eyeing five states where legalizing marijuana through the legislature may be possible.

A battle over safe injection sites looms in San Francisco, California could score a billion bucks a year in pot taxes, kratom gets massive support during the DEA's public comment period on its proposed ban, and more.

New studies suggest psilocybin could help terminal patients deal with their fears, the Ohio legislature prepares to pass asset forfeiture reform, and more.

Donald Trump's older brother, Freddy Jr., died young from booze. Will that make Trump more or less sympathetic to progressive drug policies?

The elections are over and the legislative season is yet to begin, so things are pretty quiet on the medical marijuana front. Still, here are a couple of tidbits.

On his way out of office, President Obama makes his most pro-legalization remarks yet, the FDA gives a green light for Phase 3 MDMA clinical trials, Bolivia ignores UN anti-drug treaties and signs an agreement to export coca to Ecuador, and more.

Barack Obama has already commuted the sentences of more prisoners than the last 11 presidents combined. But there is still a backlog of thousands, and time is running out.

Scholars, advocates, and a US congressman are calling on Obama to ramp up the commutation process in the final weeks of his term, the CDC issues a report calling for expanded syringe exchange, Maryland moves to address racial diversity (or the lack thereof) in the medical marijuana business, and more.